Working the Assembly Line at the Human Experimentation Factory
Carl Elliot, The Chronicle of Higher Education
"These days, if universities want to compete for clinical trials, they have do it on terms set by market forces." 

Sword and Shield: The Dual Uses of Pathogen Research
William Hoffman, Science Progress
"Because the human immune system is our most vital biodefense shield, technology that mimics its function and discloses its vulnerabilities also ratchets up the dual-use dilemma. As we know, technology rarely stays safely at home."

Drug Companies Reduce Payments to Doctors as Scrutiny Mounts
Tracy Weber and Charles Ornstein, ProPublica
"Some of the nation's top medical schools cracked down on professors who give paid promotional talks for drugmakers last year, and the firms themselves cut back on such spending in the wake of mounting scrutiny."

An MS Patient Loses Trust When She Finds Out Her Doctor Is Paid By Drug Companies
Maran Wolston, Health Affairs
"Having MS is difficult enough. The last thing I needed was to worry about whether my neurologist was acting in the best interest of the drug companies or in the best interest of me, his patient."

Why Selling Kidneys Should Be Legal
Alexander Berger, The New York Times
"People should not have to beg their friends and family for a kidney, nor die while waiting for one. Donating a kidney is one way to help. But it isn’t enough."